Jefferies raises Vital Farms stock price target to $13 on recovery

Vital Farms (VITL) remains under pressure as Jefferies reiterated Buy but trimmed its Q2 outlook and raised its price target to $13.00 from $12.00 while the stock trades at $11.30, below InvestingPro fair value of $15.67. Egg market conditions stay weak with USDA pointing to a supply recovery and softer pricing into 2027, alongside distribution gains scheduled for July/August as potential catalysts for a second-half inflection. Multiple analysts have cut ratings/targets amid guidance pressure, including William Blair to Market Perform and Telsey to Market Perform after reduced full-year guidance.

Analysis

The setup is less about one-quarter earnings noise and more about a potentially prolonged category reset that compresses both revenue growth and valuation multiples for premium egg brands. If conventional supply keeps rebuilding, the burden falls on shelf pricing and promo intensity, which usually shows up first in gross margin and then in distribution productivity; that is a worse mix than simply lower unit prices. The second-order loser is not just VITL, but any branded food company relying on a premium gap to commodity staples — if shoppers trade down, the category’s economics become more promotional and less sticky.

The important catalyst window is the next 1-3 months, when channel data and Q2/Q3 commentary will tell us whether the July/August distribution adds are actually incremental or just offsetting share loss elsewhere. A real inflection would require either a clearer rebound in scanner trends or evidence that promotional support is stabilizing velocity without destroying margin. Absent that, the market should keep assigning a lower terminal multiple because the earnings recovery story is now pushed out into a slower normalization cycle.

Contrarian view: the selloff may already reflect a very pessimistic steady state, so the stock can squeeze sharply if management shows even modest share gains while the broader egg market remains firm enough to narrow the premium gap. But that is a tactical trading thesis, not a structural one. There is no obvious direct read-through to TGT beyond a small, diffuse basket-level benefit from lower food inflation; any impact is likely too small to matter versus its broader merchandising mix.

Key Decisions for Investors

• Short VITL on strength into the next 2-6 weeks if the stock rallies on distribution headlines; use a tight stop above the prior post-earnings gap as the market may be pricing in a second-half inflection too early.
• If you want optionality instead of outright short risk, buy VITL puts or put spreads into the next earnings cycle; thesis is that margin recovery gets pushed out, while upside is capped by continued supply recovery.
• Watch for a reversal only if scanner data or management commentary shows sustained unit growth without deeper promotional spending; that would invalidate the short thesis and justify covering any bearish exposure quickly.
• No actionable standalone trade in TGT from this note; any grocery/retail benefit from softer egg pricing is too small to drive a position relative to its broader drivers.